| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/12/2013 | WO2013132054A1 Prevention of infection |
| 09/12/2013 | WO2013132053A1 Process for enriching iga |
| 09/12/2013 | WO2013132052A1 Compositions comprising secretory - like immunoglobulins |
| 09/12/2013 | WO2013132044A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 09/12/2013 | WO2013132007A1 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof |
| 09/12/2013 | WO2013131987A1 Anti-p-selectin antibody formulation |
| 09/12/2013 | WO2013102042A3 Dual variable domain immunoglobulins against il-13 and/or il-17 |
| 09/12/2013 | WO2012104014A8 A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human c44-fragment of agrin |
| 09/12/2013 | US20130239239 Lmcd1 cancer markers and methods for their use |
| 09/12/2013 | US20130239238 Immunoglobulin Cleavage Fragments and Disease Indicators and Compositions for Detecting and Binding Such |
| 09/12/2013 | US20130237691 Usp2a peptides and antibodies |
| 09/12/2013 | US20130237690 Stabilizing polypeptides which have been exposed to urea |
| 09/12/2013 | US20130237684 Reconstituted polypeptides |
| 09/12/2013 | US20130236930 Process for producing igf-1 polypeptides |
| 09/12/2013 | US20130236535 Antibodies |
| 09/12/2013 | US20130236479 Antigen |
| 09/12/2013 | US20130236478 Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction |
| 09/12/2013 | US20130236476 Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use |
| 09/12/2013 | US20130236475 Methods for reducing allergies caused by environmental allergens |
| 09/12/2013 | US20130236471 Anti il-36r antibodies |
| 09/12/2013 | US20130236470 Therapeutic agent for malignant tumors expressing mhc class ii |
| 09/12/2013 | US20130236469 Vaccine against streptococcal infections based on recombinant proteins |
| 09/12/2013 | US20130236467 Multispecific antigen binding proteins targeting hgf |
| 09/12/2013 | US20130236466 AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOF |
| 09/12/2013 | US20130236465 Epidermal growth factor receptor variant lacking exon |
| 09/12/2013 | US20130236464 Anti-clta4, anti-glut2 protein for the treatment of type 1 diabetes |
| 09/12/2013 | US20130236463 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/12/2013 | US20130236462 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/12/2013 | US20130236461 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/12/2013 | US20130236460 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/12/2013 | US20130236459 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
| 09/12/2013 | US20130236458 Dual specific binding proteins directed against il-13 and/or il-17 |
| 09/12/2013 | US20130236456 IMMUNOGLOBULIN Fc FRAGMENT TAGGING ACTIVATION OF ENDOGENOUS CD4 AND CD8 T CELLS AND ENHANCEMENT OF ANTITUMOR EFFECTS OF LENTIVECTOR IMMUNIZATION |
| 09/12/2013 | US20130236452 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 09/12/2013 | US20130236451 Antibodies directed against amyloid-beta peptide and methods using same |
| 09/12/2013 | US20130236440 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 09/12/2013 | US20130236398 Antibodies that bind to nanoparticles |
| 09/11/2013 | EP2637020A2 Predictive markers for ovarian cancer |
| 09/11/2013 | EP2636736A1 Novel anti-dr5 antibody |
| 09/11/2013 | EP2636685A1 High affinity human antibodies to human IL-4 receptor |
| 09/11/2013 | EP2636684A1 Prevention of infection |
| 09/11/2013 | EP2636683A1 Treatment of mucositis with Immunoglobulin |
| 09/11/2013 | EP2636682A1 Compositions comprising secretory-like immunoglobulins |
| 09/11/2013 | EP2636681A1 Process for enriching IgA |
| 09/11/2013 | EP2635694A2 Dual variable domain immunoglobulins and uses thereof |
| 09/11/2013 | EP2635607A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 09/11/2013 | EP2635606A1 Mmp8 inactivating antigen binding proteins |
| 09/11/2013 | EP2635605A1 Anti-her3 antibodies and compositions |
| 09/11/2013 | EP2635604A2 Pan-her antibody composition |
| 09/11/2013 | EP2635603A1 C-met antibody combinations |
| 09/11/2013 | EP2635602A1 Anti c-met antibodies |
| 09/11/2013 | EP2635601A1 Anti-il-23 antibodies |
| 09/11/2013 | EP2635600A1 Optimized method for antibody capturing by mixed mode chromatography |
| 09/11/2013 | EP2635599A1 Single unit ion exchange chromatography antibody purification |
| 09/11/2013 | EP2635593A1 Vaccines for preventing meningococcal infections |
| 09/11/2013 | EP2635303A2 Methods of treating rheumatoid arthritis using il-17 antagonists |
| 09/11/2013 | EP2635300A1 Dock-and-lock (dnl) constructs for human immunodeficiency virus (hiv) therapy |
| 09/11/2013 | EP2635298A2 Antivenom |
| 09/11/2013 | EP2635294A1 Immunotherapy against erbb-3 receptor |
| 09/11/2013 | EP2635283A2 Methods for treatment of brain injury utilizing biologics |
| 09/11/2013 | CN103298937A Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor VIII |
| 09/11/2013 | CN103298928A Method for activating helper t cell |
| 09/11/2013 | CN103298836A Method for preparing antigen to obtain antihydrophobic peptide antibody |
| 09/11/2013 | CN103298835A Method to inhibit recruitment of monocytes and macrophages by an ICAM-3 inhibitor |
| 09/11/2013 | CN103298834A Dual variable domain immunoglobulins and uses thereof |
| 09/11/2013 | CN103298833A Amyloid-beta binding proteins |
| 09/11/2013 | CN103298832A ACTRIIA binding agents and uses thereof |
| 09/11/2013 | CN103298831A NK cell modulating treatments and methods for treatment of hematological malignancies |
| 09/11/2013 | CN103298830A Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor |
| 09/11/2013 | CN103298488A Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 09/11/2013 | CN103298337A In vitro method for determining presence of type II pyrethroids |
| 09/11/2013 | CN103293316A A method of diagnosis and treatment |
| 09/11/2013 | CN103290047A A method for quickly preparing polyclonal antibodies of plant leucine-rich single transmembrane receptor protein kinase and applications of the prepared polyclonal antibodies |
| 09/11/2013 | CN103290020A Monoclonal antibody and polyclonal antibody to swine Foxp3 protein and application thereof |
| 09/11/2013 | CN103289962A Mouse anti-human CD23 monoclonal antibody and hybridoma cell strain secreting monoclonal antibody |
| 09/11/2013 | CN103289960A 扩展真核生物遗传密码 Extended eukaryotic genetic code |
| 09/11/2013 | CN103288965A Polychlorobiphenyl monoclonal antibody preparation method |
| 09/11/2013 | CN103288964A Albendazole-2-amino sulfone residue detection monoclonal antibody as well as preparation method and application thereof |
| 09/11/2013 | CN103288963A Monoclonal antibody for kitasamycin residual detection and preparation method and application thereof |
| 09/11/2013 | CN103288962A Monoclonal antibody of furacilin residue marker semicarbazide, and preparation method and application thereof |
| 09/11/2013 | CN103288961A Monoclonal antibody of furantoin residue marker aminohydantoin, and preparation method and application thereof |
| 09/11/2013 | CN103288960A Gene engineering antibody for kitasamycin residue detection, and preparation method and application thereof |
| 09/11/2013 | CN103288959A Tylosin and tilmicosin gene engineering antibody, and preparation method and application |
| 09/11/2013 | CN103288958A A single chain antibody against a cancer stem cell-specific protein CD44 and applications thereof |
| 09/11/2013 | CN103288957A Antibody drug derivative inhibiting tumor growth, its preparation method and use |
| 09/11/2013 | CN103288956A A camelized human anti-TNF-alpha genetically engineered antibody TsdAb40 and a preparation method and applications thereof |
| 09/11/2013 | CN103288955A Monoclonal antibody of anti-blue crab particle hemocyte 26.7kDa protein, and preparation method thereof |
| 09/11/2013 | CN103288954A Monoclonal antibody with rock bream iridovirus ORF049L recombinant proteins and preparation method thereof |
| 09/11/2013 | CN103288953A Method for separating and purifying functional protein in plasma |
| 09/11/2013 | CN103288872A Methyl parathion hapten, and preparation method and application thereof |
| 09/11/2013 | CN103288741A Histamine hapten, artificial antigen, antibody, as well as preparation methods and applications thereof |
| 09/11/2013 | CN103288723A Sulfonamide hapten, and preparation method and application thereof |
| 09/11/2013 | CN103288697A Acrylamide hapten, artificial antigen, antibody and preparation method and application thereof |
| 09/11/2013 | CN103288661A Preparation method and application of malachite green hapten |
| 09/11/2013 | CN103285384A Application of large granular leukocyte (LGL) protein of schistosoma japonicum katsurada |
| 09/11/2013 | CN102876636B Monoclonal antibody of hemophilus parasuis resistant OMP5 (outer membrane protein), hybridoma cell strain HPS1E2 and application |
| 09/11/2013 | CN102746398B Single-chain antibody ZL1 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof |
| 09/11/2013 | CN102516148B Half antigen and antigen of tenuazonic acid and preparation method and application thereof |
| 09/11/2013 | CN102504023B Method for preparing egg yolk antibody, egg yolk antibody prepared by method and application of egg yolk antibody |
| 09/11/2013 | CN102346191B Muscovy duck gosling plague latex particle agglutination reagent and preparation method thereof |